HCID 86730272, compound → HCID 86730270, compound
Reaction equation
C(OC([N:11]1[CH2:16][CH2:15][CH:14]([C@@H:17]([NH:19][C:20]2[N:25]=[C:24]([N:26]3[C@@H:30]([CH:31]([CH3:33])[CH3:32])[CH2:29][O:28][C:27]3=[O:34])[CH:23]=[CH:22][N:21]=2)[CH3:18])[CH2:13][CH2:12]1)=O)C1C=CC=CC=1>CO.[OH-].[OH-].[Pd+2]>[CH:31]([C@H:30]1[CH2:29][O:28][C:27](=[O:34])[N:26]1[C:24]1[CH:23]=[CH:22][N:21]=[C:20]([NH:19][C@H:17]([CH:14]2[CH2:15][CH2:16][NH:11][CH2:12][CH2:13]2)[CH3:18])[N:25]=1)([CH3:32])[CH3:33]Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 4-{(S)-1-[4-((S)-4-Isopropyl-2-oxo-oxazolidin-3-yl)-pyrimidin-2-ylamino]-ethyl}-piperidine-1-carboxylic acid benzyl ester (22 mg) in methanol (5 mL) was added palladium hydroxide on carbon (7 mg, 0.05 mmol). The reaction was then stirred at room temperature for 16 hours. The reaction is then filtered and then concentrated under vacuum. The crude material was then purified using reverse phase C18 ODB column water-acetonitrile 0.1% TFA modifier to give (S)-4-isopropyl-3-[2-((S)-1-piperidin-4-yl-ethylamino)-pyrimidin-4-yl]-oxazolidin-2-one (11 mg) in 70% yield.
Workup
- filtrationThe reaction is then filtered
- concentrationconcentrated under vacuum
- customThe crude material was then purified
Sources & evidence
- ORD record
- ord-a7ab7b86a5984181b9457e16e05d2483
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08957068B2
Reaction notes
Loading…